IndraLab

Statements


KCNQ1 inhibits disease phenotype. 1 / 1
| 1

reach
"18 Importantly, this finding was validated in a replication cohort consisting of 336 LQT1 patients from South African KCNQ1-A341V and Finnish KCNQ1-G589D founder populations, suggesting that at the very least the KCNQ1 rs2074238 SNP attenuates the LQT1 disease phenotype in multiple genetic backgrounds."